There are 3,529 papers on neurodegenerative disease in aging research: 21 trials and 474 observational studies in people, 482 in animals, 25 in cells, 2,414 reviews. The newest story, Nov 17, 2026: “Portable brain scans agree best on larger brain structures”.
Exercise protects against neurodegenerative disease.
“Polyphenols and regular physical activity are increasingly recognized as complementary lifestyle interventions that influence the gut-brain axis and contribute to neuroprotection.”
Exercise protects against neurodegenerative disease.
“physical exercise plays an important role in promoting brain health, supporting neuroplasticity and potentially serving as a preventive or complementary strategy to delay the development of neurodegenerative diseases”
Exercise protects against neurodegenerative disease.
“physical activity has been identified as a potent intervention that enhances neuroplasticity and metabolic resilience while mitigating the effects of neurodegeneration”
Exercise protects against neurodegenerative disease.
“exercise as a pleiotropic intervention that transcends single-organ influences, instead leveraging multi-tissue networks to delay aging and neurodegeneration”
Metformin protects against neurodegenerative disease in preclinical disease models.
“consistently demonstrate neuroprotective and neuromodulatory effects of metformin in models of Alzheimer's disease, Parkinson's disease, stroke, and fragile X syndrome”
Reviewin preclinical disease modelscentral nervous system
Metformin decreases neurodegenerative disease in rats (D-galactose mimetic aging model).
“the regulation of the UPR and AMPK/ERK1/2 signaling pathway by metformin significantly attenuated hearing loss, cell apoptosis and age‐related neurodegeneration”
Ergothioneine prevents neurodegenerative disease (Reviewed cellular, animal, epidemiologic, and human intervention evidence).
“Evidence that ET prevents and inhibits the development of neurodegenerative diseases, especially Alzheimer’s disease and Parkinson’s disease, has been accumulated”
ReviewReviewed cellular, animal, epidemiologic, and human intervention evidence
“Mechanisms of ET in improving cognitive function and preventing ARND were found to be through its antioxidative, anti-inflammatory and antisenescence properties.”
International Journal of Innovative Technologies in Social Science·
GLP-1 receptor agonists protect against neurodegenerative disease.
“Glucagon-like peptide-1 receptor agonists (GLP1-RAs), widely used for type 2 diabetes mellitus, are emerging as promising neuroprotective therapies in Alzheimer's disease (AD) and Parkinson's disease (PD).”
Reviewin Alzheimer's disease and Parkinson's disease, as reviewed from preclinical and clinical studies
Rapamycin decreases neurodegenerative disease in rats (aging rat brain).
“provided significant protection to aging rat brain by reducing the aging-induced oxidative stress, apoptotic cell death, and markers of neurodegeneration”
Nicotinamide riboside decreases neurodegenerative disease in mice after LPS administration.
“or nicotinamide riboside (NR), an NAD+ precursor, increased NAD+ level, and significantly suppressed induction of cytokines and chemokines, glial activation and subsequent neurodegeneration after LPS administration”
Ketogenic diet protects against neurodegenerative disease in humans and animal models.
“KD is beneficial to neurodegenerative diseases through modulating central and peripheral metabolism, mitochondrial function, inflammation, oxidative stress, autophagy, and the gut microbiome”
Neurodegenerative disease is linked with worse cognitive function in humans (β = 1.27, p = 0.01).
“neurodegenerative disease was strongly associated with poorer outcomes in three of the four follow-up measures (SBT: β = 1.27, p = 0.01; EQ-5D-5L: β = 1.43, p < 0.001; BI: β = -1.63, p < 0.001)”
Neurodegenerative disease impairs cognitive function in humans.
“Specifically, our article explores the pathological processes underlying neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Huntington's diseases, shedding light on the structural alterations and functional impairments that accompany these conditions.”
Neurodegenerative disease is linked with lower intrinsic capacity in humans (β = -0.587).
“neurodegenerative diseases, including Parkinson disease and Alzheimer disease, demonstrated the strongest negative association with IC (β = -0.587, P < .01)”
Neurodegenerative disease is linked with higher ID4-resembling sIndel process in neurons in humans (compared with control neurons) (22% ALS, 76% FTD, 61% AD neurons versus 2% control neurons).
“an sIndel process affecting 22% of ALS, 76% of FTD, and 61% of AD neurons-but only 2% of control neurons”
Somatic single-nucleotide variants and insertions/deletions
↑upin humans1
1 study
Neurodegenerative disease is linked with higher somatic single-nucleotide variants and insertions/deletions in humans (single-cell sequencing of neurons from postmortem brains compared with controls).
“Single-cell whole-genome sequencing of 469 neurons from C9ORF72 ALS, C9ORF72 FTD, AD, and control brains revealed increased somatic single-nucleotide variants (sSNVs) and insertions/deletions (sIndels) in all three diseases.”
Humanssingle-cell sequencing of neurons from postmortem brains compared with controlsneuronn = 469
Neurodegenerative disease increases RPS24 in mice (Alzheimer's disease, Parkinson's disease, and Huntington's disease).
“Using S24-PKE-specific antibodies, we verified increased expression of this protein variant in brains with AD, PD, and HD, and in relevant mouse models.”
AnimalsAlzheimer's disease, Parkinson's disease, and Huntington's diseasebrain
Autophagy protects against neurodegenerative disease.
“Impairment of glial autophagy has been implicated in non-cell-autonomous neurodegeneration, leading to excitotoxicity, myelin damage, the emergence of senescence-associated secretory phenotypes, and persistent neuroinflammation.”
Autophagy protects against neurodegenerative disease in preclinical models of age-related neurodegenerative diseases.
“preclinical models of age-related neurodegenerative diseases demonstrate pathology modulating effect of autophagy induction, implicating its potential to treat such disorders.”
Reviewin preclinical models of age-related neurodegenerative diseases
“The therapeutic significance of SIRT1 has been put into perspective through a comprehensive discussion about its ameliorating potential against neurodegenerative stimuli”
Sirtuin signaling protects against neurodegenerative disease.
“It also plays a neuroprotective role by modulating several biological pathways such as apoptosis, DNA repair, protein aggregation, and inflammatory processes associated with ageing and neurodegenerative diseases.”
“An increase in endogenous sirtuin activity seems to mediate the protective effect that enhancing NAD+ availability confers in several models of neurodegeneration and age-related diseases.”
Reviewprotective effect of enhancing NAD+ availability in models of neurodegeneration and age-related diseases
Sirtuin signaling protects against neurodegenerative disease.
“mitochondrial sirtuin function has been implicated in the protection against age-related pathologies, including neurodegeneration, cardiopathologies, and insulin resistance.”
“Neuroinflammation is a hallmark of many neurodegenerative diseases (NDs) and plays a fundamental role in mediating the onset and progression of disease.”
“Mitochondrial dysfunction occurs early on and acts causally in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD).”
Cellular senescence raises the risk of neurodegenerative disease.
“cellular senescence, particularly in microglia, the innate immune cells of the central nervous system, has become a significant contributor to neurodegeneration”
Inflammation raises the risk of neurodegenerative disease in humans.
“chronic low-grade inflammation, which contributes to the pathogenesis of numerous age-related conditions, including cancer and neurodegenerative diseases (NDDs).”
Neurodegenerative disease is associated with inflammation in silico.
“The results revealed consistent dysregulation of pathways related to neuronal signaling, synaptic function, mitochondrial metabolism, neuroinflammation, and proteostasis.”
Inflammation raises the risk of neurodegenerative disease in brains of individuals with Alzheimer's Disease and Parkinson's Disease.
“Neuroinflammation triggered by amyloid proteins and protein aggregates accelerates neurodegeneration due to increased cytokines and chemokines in the brains of individuals with Alzheimer's Disease and Parkinson's Disease.”
Reviewin brains of individuals with Alzheimer's Disease and Parkinson's Diseasebrain
Inflammation raises the risk of neurodegenerative disease in humans with aging.
“Chronic inflammation contributes to a variety of age-related diseases, such as neurodegenerative disease, cancer, infectious disease, and autoimmune diseases.”
Inflammation raises the risk of neurodegenerative disease.
“increased oxidative stress, and neuroinflammation, all of which contribute to the progression of NDs such as Alzheimer's (AD), Parkinson's disease (PD), Huntington's disease (HD)”
Inflammation is associated with neurodegenerative disease in humans.
“Genome-wide association studies (GWAS) especially in Alzheimer's disease patients and research in Parkinson's disease have implicated inflammation and the innate immune response as risk factors.”
Inflammation raises the risk of neurodegenerative disease in humans during normal brain aging and under certain pathological conditions.
“this crosstalk can go beyond physiological control, resulting in an unresolved inflammatory response of the CNS-resident immune cells that might initiate and propagate the progression of severe tissue damage and neurodegeneration”
Reviewduring normal brain aging and under certain pathological conditionscentral nervous system
Oxidative stress and ROS signaling raises the risk of neurodegenerative disease in humans.
“a disturbed endogenous pro-oxidants/antioxidants balance is considered the crucial detrimental factor that makes the brain vulnerable to aging and progressive neurodegeneration.”
Oxidative stress and ROS signaling is associated with neurodegenerative disease.
“Emerging evidence also highlights the relationship between oxidative stress and age-related pathologies, such as protein misfolding-based neurodegenerative diseases”
Oxidative stress and ROS signaling is associated with neurodegenerative disease.
“Weakening or deregulation of these self-protecting defenses orchestrated by DHA is associated with normal aging but also, more worryingly, with the development of neurodegenerative diseases.”
Oxidative stress and ROS signaling raises the risk of neurodegenerative disease.
“Especially in aging and neurodegenerative diseases, oxidative stress leads to aberrant cysteine oxidations that affect protein structure and function leading to neurodegeneration”
Type 2 diabetes is linked with a higher risk of neurodegenerative disease in humans (initially diagnosed with T2D vs matched controls) (HR: 1.23, 95% CI: 1.22, 1.25, p < 0.001).
“The overall incidence of NDs was higher in the T2D group than that in the control group (HR: 1.23, 95% CI: 1.22, 1.25, p < 0.001).”
Humansinitially diagnosed with T2D vs matched controls10 years
Type 2 diabetes is linked with a higher risk of neurodegenerative disease in humans (compared with matched controls) (adjusted HR 1.23 (95% CI, 1.22 ~ 1.25)).
“The adjusted HR for ND in the T2D group compared with the control group was 1.23 (95% CI, 1.22 ~ 1.25; P < 0.001).”
Humanscompared with matched controls10-year follow-up
Type 2 diabetes raises the risk of neurodegenerative disease.
“Through prion-like cross-seeding, IAPP interacts with Aβ, tau, α-synuclein, and PrP, linking T2D as a major risk factor for neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.”
Autophagy is associated with neurodegenerative disease (Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis).
“Long-term changes in mitochondrial function, autophagy dysfunction, and immune activation are commonalities shared across these age-related disorders.”
ReviewAlzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis
Frailty is linked with a higher risk of neurodegenerative disease in AMD patients (OR 3.09, 95% CI 1.58-6.07).
“frailty was linked to neurodegenerative diseases (odds ratio [OR] 3.09 [95% CI 1.58-6.07]), neurovascular diseases (OR 3.77 [95% CI 2.16-6.60]), and mental diseases (OR 2.09 [95% CI 1.12-3.93]).”
Neurodegenerative disease is associated with frailty in humans (by Frailty Index and Frailty Phenotype) (11% by Frailty Index, 14% by Frailty Phenotype).
“frailty was identified in 11% and 14% of participants according to the FI and FP, respectively.”
Humansby Frailty Index and Frailty Phenotypen = 150
Physical activity lowers the risk of neurodegenerative disease.
“Research from both preclinical and clinical studies repeatedly reveals associations between regular physical activity and improved cognitive function, augmented brain structural integrity, and less neurodegeneration.”
International Journal of Innovative Technologies in Social Science·
Physical activity lowers the risk of neurodegenerative disease in humans.
“Long-term physical activity not only enhances inhibitory control but also reduces the risk of age-related cognitive decline and neurodegenerative diseases.”
circadian disruption raises the risk of neurodegenerative disease in aging.
“age‐related disruptions in circadian rhythms not only predispose individuals to neurodegenerative diseases but also promote the rate of disease progression.”
circadian disruption raises the risk of neurodegenerative disease.
“circadian and sleep disturbances, which have long been considered symptoms of many neurodegenerative conditions, may actually drive pathogenesis early in the course of these diseases”
Ferroptosis is associated with neurodegenerative disease.
“Ferroptosis, an iron-mediated lipid peroxidation-induced programmed cell death, has recently been implicated in neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD).”
Portable and standard brain scans had volume-agreement scores ranging from 0.29 to 0.95, with the closest matches for larger structures.Portable and standard brain scans had volume-agreement scores ranging from 0.29 to 0.95, with the closest matches for larger structures.